Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118926

Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.

R Pfundt, F van Ruissen, I M van Vlijmen-Willems, H A Alkemade, P L Zeeuwen, P H Jap, H Dijkman, J Fransen, H Croes, P E van Erp, and J Schalkwijk

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Pfundt, R. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by van Ruissen, F. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by van Vlijmen-Willems, I. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Alkemade, H. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Zeeuwen, P. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Jap, P. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Dijkman, H. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Fransen, J. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Croes, H. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by van Erp, P. in: JCI | PubMed | Google Scholar

Department of Dermatology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

Find articles by Schalkwijk, J. in: JCI | PubMed | Google Scholar

Published September 15, 1996 - More info

Published in Volume 98, Issue 6 on September 15, 1996
J Clin Invest. 1996;98(6):1389–1399. https://doi.org/10.1172/JCI118926.
© 1996 The American Society for Clinical Investigation
Published September 15, 1996 - Version history
View PDF
Abstract

Skin-derived antileukoproteinase (SKALP), also known as elafin, is a serine proteinase inhibitor first discovered in keratinocytes from hyperproliferative human epidermis. In addition to the proteinase inhibiting domain which is directed against polymorphonuclear leukocyte (PMN) derived enzymes such as elastase and proteinase 3, SKALP contains multiple transglutaminase (TGase) substrate domains which enable crosslinking to extracellular and cell envelope proteins. Here we show that SKALP is constitutively expressed in several epithelia that are continuously subjected to inflammatory stimuli, such as the oral cavity and the vagina where it co-localizes with type 1 TGase. All epithelia from sterile body cavities are negative for SKALP. In general, stratified squamous epithelia are positive, whereas pseudostratified epithelia, simple/glandular epithelia and normal epidermis are negative. SKALP was found in fetal tissues of the oral cavity from 17 wk gestation onwards where it continued to be expressed up to adult life. Remarkably, in fetal epidermis SKALP was found from week 28 onwards, but was downregulated to undetectable levels in neonatal skin within three months, suggesting a role during pregnancy in feto-maternal interactions or in the early maturation phase of the epidermis. Immunoelectron microscopy revealed the presence of SKALP in secretory vesicles including the lamellar granules. In culture models for epidermal keratinocytes we found that expression of the endogenous SKALP gene provided protection against cell detachment caused by purified elastase or activated PMNs. Addition of exogenous recombinant SKALP fully protected the keratinocytes against PMN-dependent detachment whereas superoxide dismutase and catalase were only marginally effective. These findings strongly suggest that the constitutive expression of SKALP in squamous epithelia, and the inducible expression in epidermis participate in the control of epithelial integrity, by inhibiting PMN derived proteinases.

Version history
  • Version 1 (September 15, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts